CV Sciences and UC San Diego Publish Study of Cannabidiol Efficacy in Treating Nicotine Dependence

CV Sciences, Inc. has announced progress toward its goal of developing and commercializing a CBD-based pharmaceutical to treat nicotine addiction in smokeless tobacco users. The company, in collaboration with researchers from the University of California, San Diego (“UC San Diego”), published a preclinical study demonstrating the efficacy of chronic CBD treatment in reducing nicotine dependence ...